Lumexa Imaging Holdings Inc 's Quick Ratio

LMRI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth

Lumexa Imaging Holdings Inc 's Cash & cash equivalent grew by 36.07 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Lumexa Imaging Holdings Inc 's Quick Ratio to 0.39, Quick Ratio remained below Lumexa Imaging Holdings Inc average.

Within Medical Laboratories industry 24 other companies have achieved higher Quick Ratio than Lumexa Imaging Holdings Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3031 to 3054.

Explain Quick Ratio?
How much Cash & cash equivalents LMRI�s has?
What are LMRI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LMRI Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q2	Q1
Y / Y Current Liabilities Change	-	-	-	-	-
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	0.39	0.32	0.6	-	-
LMRI's Total Ranking	# 3054	# 3031	#	#	#
Seq. Current Liabilities Change	12.93 %	61.13 %	-	-	-
Seq. Cash & cash equivalent Change	36.07 %	-12.92 %	-	-	-

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 25
Healthcare Sector	# 762
Overall Market	# 2850

Quick Ratio Statistics
High	Average	Low
0.6	0.44	0.32
(Dec 31 2025)		(Mar 31 2026)

Financial Statements
Lumexa Imaging Holdings Inc 's Current Liabilities	$ 178 Millions	Visit LMRI's Balance sheet
Lumexa Imaging Holdings Inc 's Cash & cash equivalent	$ 70 Millions	Visit LMRI's Balance sheet
Source of LMRI's Sales		Visit LMRI's Sales by Geography

Cumulative Lumexa Imaging Holdings Inc 's Quick Ratio

LMRI's Quick Ratio for the trailling 12 Months

LMRI Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	12 Months	12 Months
Y / Y Current Liabilities TTM Growth	-	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	0.41	0.43	0.6	-	-
Total Ranking TTM	# 3054	# 3031	#
Seq. Current Liabilities TTM Growth	69.68 %	161.13 %	-	-	-
Seq. Cash & cash equivalent TTM Growth	63.34 %	87.08 %	-	-	-

Quick ratio ranking by company, industry and sector >> Back to LMRI Financial Strength Comparisons >> Go to Compare LMRI Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q2 2026 to $178.36 millions, cumulative Quick Ratio decreased to 0.41 below the Lumexa Imaging Holdings Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 24 other companies have achieved higher Quick Ratio than Lumexa Imaging Holdings Inc . While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents LMRI�s has?
What are LMRI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 25
Healthcare Sector	# 762
Within the Market	# 3054

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.6	0.44	0.32
(Dec 31 2025)		(Mar 31 2026)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions
Ispecimen inc	0.43	$ 4.426 Millions	$ 10.196 Millions
Quest Diagnostics Inc	0.40	$ 720.000 Millions	$ 1,788.000 Millions
Lumexa Imaging Holdings Inc	0.39	$ 69.705 Millions	$ 178.355 Millions
Medpace Holdings Inc	0.35	$ 502.688 Millions	$ 1,435.429 Millions
American Shared Hospital Services	0.30	$ 6.761 Millions	$ 22.424 Millions
Nuo Therapeutics, Inc.	0.29	$ 0.449 Millions	$ 1.554 Millions
Icon Plc	0.24	$ 930.885 Millions	$ 3,934.665 Millions
Fortrea Holdings Inc	0.17	$ 168.600 Millions	$ 963.700 Millions
Charles River Laboratories International inc	0.17	$ 192.025 Millions	$ 1,134.746 Millions
Nrc Health	0.10	$ 3.327 Millions	$ 35.019 Millions

Date modified: 2026-09-12T06:28:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.